Trial Profile
Advair - CRP study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jun 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- Acronyms ABC
- 01 Jun 2008 Results have been reported in the American Journal of Respiratory Critical Care Medicine.
- 01 Jun 2008 Status changed from recruiting to completed, based on published results.
- 19 Nov 2006 New trial record.